Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
50,204,902
-
Shares change
-
+1,732,549
-
Total reported value, excl. options
-
$861,938,071
-
Value change
-
+$12,311,173
-
Put/Call ratio
-
1.52%
-
Number of buys
-
65
-
Number of sells
-
-55
-
Price
-
$17.17
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q2 2021
144 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q2 2021.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50,204,902 shares
of 86,559,040 outstanding shares and own 58% of the company stock.
Largest 10 shareholders include Avidity Partners Management LP (4,615,000 shares), BlackRock Inc. (3,519,894 shares), STATE STREET CORP (3,170,432 shares), Avoro Capital Advisors LLC (3,000,000 shares), Nantahala Capital Management, LLC (2,593,337 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,491,272 shares), BVF INC/IL (2,486,429 shares), BOXER CAPITAL, LLC (2,287,782 shares), PFM Health Sciences, LP (2,144,881 shares), and VANGUARD GROUP INC (2,108,748 shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.